Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-driven Melanoma

Cancer Research - United States
doi 10.1158/0008-5472.can-19-1784
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Communication About Family Members' Risk of Melanoma

Archives of Dermatology
2012English

Regeneration of the Heart in Diabetes by Selective Copper Chelation

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

BrafV600E Cooperates With Pten Loss to Induce Metastatic Melanoma

Nature Genetics
Genetics
2009English

Proteasome Inhibition Leads to the Activation of All Members of the Heat-Shock-Factor Family

FEBS Journal
BiochemistryCell BiologyMolecular Biology
1998English

Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas

Oncotarget
Oncology
2016English

Vasostatin Increases Oxygenation of B16-F10 Melanoma Tumors and Raises Therapeutic Efficacy of Cyclophosphamide.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Selective Inhibition of BCL2 Shows Antitumor Effects in Lung Cancer

Cancer Discovery
Oncology
2015English

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Frontiers in Neurology
Neurology
2017English

Copper Induces – And Copper Chelation by Tetrathiomolybdate Inhibits – Endothelial Activationin Vitro

Redox Report
BiochemistryClinical BiochemistryCell BiologyPhysiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy